Study on the potential of Sanghuangporus sanghuang and its components as COVID-19 spike protein receptor binding domain inhibitors

Authors:

Abstract
No abstract available
Funding Information
  • Ministry of Science and Technology, Taiwan (108–2320-B-039–009-)
  • Asia University (ASIA-109-CMUH-06)
  • Asia University (ASIA-110-CMUH-02)
  • China Medical University (CMU108-MF-117)
  • China Medical University, Taiwan
  • National Science Council

This publication has 48 references indexed in Scilit: